Search Results - "Tan, Malinda S"

Refine Results
  1. 1

    Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants: An Academic Medical Center Cohort Study by Gomez Lumbreras, Ainhoa, Tan, Malinda S., Moorman-Bishir, Krystal, Ilham, Sabrina, Malone, Daniel C.

    Published in Journal of cardiovascular pharmacology (01-12-2022)
    “…Previous research has identified risk factors that may affect the risk of bleeding when individuals are exposed to oral anticoagulants. It is unclear if the…”
    Get full text
    Journal Article
  2. 2

    A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS) by Villa-Zapata, Lorenzo, Gómez-Lumbreras, Ainhoa, Horn, John, Tan, Malinda S., Boyce, Richard D., Malone, Daniel C.

    Published in Drug safety (01-08-2022)
    “…Introduction Tizanidine is primarily metabolized via cytochrome P450 (CYP) 1A2 and therefore medications that inhibit the enzyme will affect the clearance of…”
    Get full text
    Journal Article
  3. 3

    Cancer incidence in immunocompromised patients: a single-center cohort study by Ilham, Sabrina, Willis, Connor, Kim, Kibum, Chung, Karen C, Wood, Brenda M, Tan, Malinda S, Tan, Chia Jie, Nguyen, Danielle T, Brixner, Diana I, Stenehjem, David D

    Published in BMC cancer (09-01-2023)
    “…Diminished immune defense plays an important role in cancer development. Cancer risk in immunocompromised patients may differ. Identifying individuals with…”
    Get full text
    Journal Article
  4. 4

    Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes by Gallo, Tyler, Heise, C William, Woosley, Raymond L, Tisdale, James E, Tan, Malinda S, Gephart, Sheila M, Antonescu, Corneliu C, Malone, Daniel C

    Published in Journal of the American Heart Association (07-06-2022)
    “…Background Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP…”
    Get full text
    Journal Article
  5. 5

    A machine learning evaluation of patient characteristics associated with prescribing of guideline-directed medical therapy for heart failure by Kim, Rachel, Suresh, Krithika, Rosenberg, Michael A, Tan, Malinda S, Malone, Daniel C, Allen, Larry A, Kao, David P, Anderson, Heather D, Tiwari, Premanand, Trinkley, Katy E

    Published in Frontiers in cardiovascular medicine (21-06-2023)
    “…Patients with heart failure and reduced ejection fraction (HFrEF) are consistently underprescribed guideline-directed medications. Although many barriers to…”
    Get full text
    Journal Article
  6. 6

    Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction by Gomez Lumbreras, Ainhoa, Reese, Thomas J, Del Fiol, Guilherme, Tan, Malinda S, Butler, Jorie M, Hurwitz, Jason T, Brown, Mary, Kawamoto, Kensaku, Thiess, Henrik, Wright, Maria, Malone, Daniel C

    Published in JMIR formative research (01-10-2022)
    “…Background Warnings about drug-drug interactions (DDIs) between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) within electronic health records…”
    Get full text
    Journal Article
  7. 7

    Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure by Tan, Malinda S., Gomez-Lumbreras, Ainhoa, Villa-Zapata, Lorenzo, Malone, Daniel C.

    Published in Rheumatology international (01-12-2022)
    “…Colchicine is increasingly used as the number of potential indications expands. However, it also has a narrow therapeutic index that is associated with…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management by Hansten, Philip D., Tan, Malinda S., Horn, John R., Gomez-Lumbreras, Ainhoa, Villa-Zapata, Lorenzo, Boyce, Richard D., Subbian, Vignesh, Romero, Andrew, Gephart, Sheila, Malone, Daniel C.

    Published in Drug safety (01-03-2023)
    “…Colchicine is useful for the prevention and treatment of gout and a variety of other disorders. It is a substrate for CYP3A4 and P-glycoprotein (P-gp), and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective by Gómez Lumbreras, Ainhoa, Tan, Malinda S., Villa-Zapata, Lorenzo, Ilham, Sabrina, Earl, Jacob C., Malone, Daniel C.

    “…To determine the cost-effectiveness of anti-obesity medications (AOM): tirzepatide, semaglutide, liraglutide, phentermine plus topiramate (PpT), and naltrexone…”
    Get full text
    Journal Article
  12. 12

    Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)” by Malone, Daniel C., Villa-Zapata, Lorenzo, Gómez-Lumbreras, Ainhoa, Horn, John, Tan, Malinda S., Boyce, Richard D.

    Published in Drug safety (01-12-2022)
    “…Malone et al respond to comments by Dr. Yoshiro Noguchi concerning their paper entitled "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities by Tan, Malinda S., Heise, C. William, Gallo, Tyler, Tisdale, James E., Woosley, Raymond L., Antonescu, Corneliu C., Gephart, Sheila M., Malone, Daniel C.

    Published in Journal of electrocardiology (01-03-2023)
    “…To evaluate the relationship between a modified Tisdale QTc-risk score (QTc-RS) and inpatient mortality and length of stay in a broad inpatient population with…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effect of treatment intensification on glycemic control in patients with subcontrolled type 2 diabetes who failed on two oral antidiabetic agents by Tan, Malinda S., Kim, Kibum, Olsen, Cody J., Brixner, Diana I.

    Published in Diabetes epidemiology and management (01-01-2023)
    “…Treatment intensification (TI) may help patients with type 2 diabetes mellitus (T2DM) achieve target hemoglobin A1c (A1c) < 7.0%. This study aimed to measure…”
    Get full text
    Journal Article
  17. 17

    Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support by Zhang, Tianyi, Gephart, Sheila M, Subbian, Vignesh, Boyce, Richard D, Villa-Zapata, Lorenzo, Tan, Malinda S, Horn, John, Gomez-Lumbreras, Ainhoa, Romero, Andrew V, Malone, Daniel C

    Published in Applied clinical informatics (01-08-2023)
    “…Despite the benefits of the tailored drug-drug interaction (DDI) alerts and the broad dissemination strategy, the uptake of our tailored DDI alert algorithms…”
    Get full text
    Journal Article
  18. 18

    Abstract 11465: Impact of a QTc Risk Score Advisory on Mortality in Intensive Care Units by Malone, Daniel, Heise, C., Tan, Malinda S, Gallo, Tyler, Tisdale, James E, Woosley, Raymond, Antonescu, Corneliu, Gephart, Sheila

    Published in Circulation (New York, N.Y.) (08-11-2022)
    “…IntroductionProlongation of the heart rate-corrected QT interval (QTc) is associated with increased mortality. We hypothesized that incorporation of a QTc…”
    Get full text
    Journal Article
  19. 19
  20. 20